Mergers & Acquisitions ·
Creative Medical Technology Holdings acquires 80% stake in BioDefense for $200,000 and stock
CELZCreative Medical Technology Holdings, Inc.
On September 24, 2026, Creative Medical Technology Holdings, Inc. entered into a Stock Purchase Agreement with Creative Acquisition Corp. to acquire 12,000,000 additional shares of BioDefense, Inc., bringing its total ownership to 16,000,000 shares, or 80% of BioDefense's outstanding common stock. The transaction consideration consisted of $200,000 in cash and 1,000,000 shares of Creative Medical Technology Holdings' common stock issued via private placement. Timothy Warbington, the Company's President and CEO, also serves as Chairman and CEO of Creative Acquisition Corp., which retains a 20% stake in BioDefense. This acquisition establishes majority control over BioDefense, expanding the Company's portfolio into medical technology solutions.